Mycoplasma Pneumoniae Infection Is A Risk Factor For Developing Allergic Diseases

Authors

  • Aseel Muthana Yousif alsammaraie

DOI:

https://doi.org/10.47750/pnr.2022.13.S08.037

Abstract

Mycoplasma pneumoniae (MP) infection is the dominant cause of pneumonia in children. We sought to determine the relationship between MP infection and secondary allergic disease and to clarify the associated mechanisms of inflammatory response. This study was performed to investigate the patient immune status by determining the correlation between MP infection, immunoglobulin E (IgE) levels, and a spectrum of associated serum cytokines. Serum IgE, IL-4, IL-6, and IL-10 levels for MP patients in the acute phase were obviously higher than those in the recovery phase. MP patients with allergic conditions had increased serum IgE levels and increased IL-4/INF-γ ratio, and IgE and Eosinophil Cationic Protein were further elevated in patients who eventually developed secondary asthma changes. Patients with severe pneumonia and high clinical pulmonary infection scores presented higher levels of IL-4 and IL-5 in serum than those with low scores. The proportion of CD4+ and CD8+ T cells that secreted IL-4 was significantly increased in MPP patients with elevated IgE. This information demonstrates a significant correlation between MP infection and IgE levels, which is associated with a Th1/Th2 cytokine imbalance.

Downloads

Published

2022-10-28 — Updated on 2022-10-30

Versions

Issue

Section

Articles

How to Cite

Mycoplasma Pneumoniae Infection Is A Risk Factor For Developing Allergic Diseases. (2022). Journal of Pharmaceutical Negative Results, 240-249. https://doi.org/10.47750/pnr.2022.13.S08.037 (Original work published 2022)